4'-demethyl-epipodophyllotoxin-beta-d-thenylidene glucoside ) has been proved , in clinical screening , to be able to induce apparently complete remissions and pronounced though incomplete regressions in hodgkin 's disease , reticulosarcoma , and bladder cancer , as well as incomplete regressions in lymphosarcoma .
C0019829
hodgkin 's disease
C0024299
lymphosarcoma